Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism

 

Recent News:

OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints
September 23, 2014

Rayaldee™ Phase 3 Trial Meets Primary Endpoints
August 11, 2014

OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy
August 7, 2014

 
     
 

 

© 2014 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use